Cited by 265Bariatric Surgery and OutcomesMinimally Invasive Surgical TechniquesDiabetes, Cardiovascular Risks, and Lipoproteins

Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids

Open access
Kohli, Rohit, Bradley, David, Setchell, Kenneth D., Eagon, J. Christopher, Abumrad, Nada, Klein, Samuel·2013·The Journal of Clinical Endocrinology & Metabolism

Abstract

CONTEXT: It has been hypothesized that increased plasma bile acids (BAs) contribute to metabolic improvements after Roux-en-Y gastric bypass (RYGB) surgery by the G protein-coupled receptor TGR5-mediated effects on glucagon-like peptide-1 secretion and thyroid hormones. OBJECTIVE: The objective of this study was to evaluate the importance of bariatric surgery-induced alterations in BA physiology on factors that regulate glucose homeostasis (insulin secretion and sensitivity) and energy metabolism (resting energy expenditure and thyroid hormone axis). DESIGN, PARTICIPANTS, INTERVENTION, AND MAIN OUTCOME MEASURE: Eighteen extremely obese subjects were studied before and after 20% weight loss, induced by either laparoscopic adjustable gastric banding (LAGB) (n = 10) or RYGB surgery (n = 8). RESULTS: Plasma BAs more than doubled after RYGB [fasting: 1.08 (0.26-1.42) to 2.28 (1.59-3.28) μmol/L, P = .03; postprandial: 2.46 ± 1.59 to 6.00 ± 2.75 μmol/L, P = .01] but were either lower or did not change after LAGB [fasting: 1.80 (1.49-2.19) to 0.92 (0.73-1.15) μmol/L, P = .02; postprandial: 3.71 ± 2.61 to 2.82 ± 1.75 μmol/L, P = .14]. Skeletal muscle expression of TGR5 targets, Kir6.2 and cyclooxygenase IV, increased after RYGB but not LAGB. Surgery-induced changes in BAs were associated with increased peak postprandial plasma glucagon-like peptide-1 (r(2) = 0.509, P = .001) and decreased serum TSH (r(2) = 0.562, P < .001) but did not correlate with the change in insulin response to a meal (r(2) = 0.013, P = .658), insulin sensitivity (assessed as insulin stimulated glucose disposal during a hyperinsulinemic-euglycemic clamp procedure) (r(2) = 0.001, P = .995), or resting energy expenditure (r(2) = 0.004, P = .807). CONCLUSIONS: Compared with LAGB, RYGB increases circulating BAs and TGR5 signaling, but this increase in BAs is not a significant predictor of changes in glucose homeostasis or energy metabolism.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2012-3736

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 20 · Cited by 265

Authors
Kohli, R., Bradley, D., Setchell, K. D., Eagon, J. C., Abumrad, N., & Klein, S.
Affiliations
  • Division of Gastroenterology, Hepatology, and Nutrition (R.K.), Cincinnati, Ohio 45229
  • Washington University in St. Louis (US)
  • Cincinnati Children's Hospital Medical Center (US)
Corresponding author
Klein, Samuel
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2013-04-01
Volume
98
Issue
4
Pages
E708-E712
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2027954881
Cited by
265
References
20
Citations by year
2026: 2 · 2025: 6 · 2024: 7 · 2023: 13 · 2022: 14 · 2021: 15 · 2020: 18 · 2019: 30 · 2018: 19 · 2017: 40 · 2016: 31 · 2015: 42 · 2014: 18 · 2013: 10
FWCI
33.16
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01dk060022-19, UL1TR000448, DK56341, RR024992, UL1‐RR024992)
  • National Heart, Lung, and Blood Institute (T32HL007456)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK084310, DK37948, DK56341, K08DK084310, R01DK037948, U01 DK08505, R01-DK-060022, P30DK056341, P30DK020579)
  • National Center for Research Resources (UL1RR024992)
  • Ethicon Endo-Surgery
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
  • Health Sciences › Medicine › Surgery › Minimally Invasive Surgical Techniques
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
Roux-en-Y gastric bypass, laparoscopic adjustable gastric banding, bariatric surgery, bile acids, TGR5, glucagon-like peptide-1, thyroid-stimulating hormone, insulin sensitivity, insulin secretion, resting energy expenditure, Kir6.2, obesity, weight loss, glucose homeostasis
MeSH terms
Adult, Anastomosis, Roux-en-Y, Bile Acids and Salts, Energy Metabolism, Fasting, Female, Humans, Male, Middle Aged, Obesity, Morbid, Laparoscopy, Rest, Gastric Bypass, Gastroplasty, Weight Loss, Up-Regulation, Postprandial Period

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review